Gonorrhea vaccine safety study
This trial tests a new vaccine designed to protect against gonorrhea, a common sexually transmitted infection. The study checks how safe the vaccine is and how well it trains the immune system to fight the bacteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You are in good general health.
- You have never had gonorrhea before.
- You have never been vaccinated with Bexsero or another meningitis B vaccine.
- You are not pregnant or planning to become pregnant, and you are willing to use highly effective birth control if you can get pregnant.
- You can attend all follow-up visits and complete a diary of your symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial analyzes throat bacteria in partners of people with gonorrhea to better understand the infection. It may help improve detection and care for those at risk.
This trial tests a new meningitis vaccine (GNG-DE) to see how well it works compared to a vaccine already on the market. It might help protect you or your child from meningococcal disease.
This study evaluates a new rapid test for gonorrhea designed for women. You'll provide vaginal swab samples and complete a brief counseling session to help researchers understand how well the test works and whether patients can use it correctly.
This trial tests a new vaccine to prevent Group B Strep (GBS) infection, given alone or with the Tdap vaccine. It aims to see if the combination is safe and works well in healthy women aged 18 to 49.
This trial tests a new vaccine that helps protect against 6 types of meningococcal bacteria, which can cause serious infections like meningitis. It is for healthy people aged 2 to 59 years.
This trial tests a new vaccine called DX-104 to see if it is safe and helps the body fight meningitis B. Healthy adults aged 18-50 can join to help find a better way to prevent this infection.
Hear when a new Neisseria Gonorrhea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.